Ping An Biomedical Co., Ltd. (PASW)

Ping An Biomedical Income Statement

Financials in millions CNY. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Revenue	34.15	87.62	82.56	114.55	99.52
Revenue Growth (YoY)	-61.03%	6.13%	-27.92%	15.10%	79.43%
Cost of Revenue	33.2	82.21	78.32	100.4	85.25
Gross Profit	0.95	5.42	4.24	14.14	14.27
Selling, General & Admin	6.31	5.3	3.6	3.52	3.76
Operating Expenses	15.65	5.42	3.63	3.33	6
Operating Income	-14.7	-0	0.61	10.82	8.27
Interest Expense	-0.31	-0.71	-1.74	-1.57	-1.36
Interest & Investment Income	0.33	0	0.16	0.04	0
Currency Exchange Gain (Loss)	-	-0.01	0.21	-0	0.19
Other Non Operating Income (Expenses)	-0	0.03	0.8	0.34	0.72
Pretax Income	-14.68	-0.68	0.04	9.63	7.82
Income Tax Expense	-1.86	0.6	1.04	2.4	2.61
Net Income	-12.83	-1.28	-0.99	7.23	5.21
Net Income to Common	-12.83	-1.28	-0.99	7.23	5.21
Net Income Growth	-	-	-	38.61%	170.96%
Shares Outstanding (Basic)	18	18	18	18	18
Shares Outstanding (Diluted)	18	18	18	18	18
Shares Change (YoY)	2.66%	-	-	-	-
EPS (Basic)	-0.69	-0.07	-0.06	0.40	0.29
EPS (Diluted)	-0.69	-0.07	-0.06	0.40	0.29
EPS Growth	-	-	-	38.61%	170.96%
Free Cash Flow	-6.43	14.63	-6.08	21.06	-31.4
Free Cash Flow Per Share	-0.35	0.81	-0.34	1.17	-1.74
Gross Margin	2.78%	6.18%	5.14%	12.35%	14.34%
Operating Margin	-43.05%	-0.00%	0.74%	9.44%	8.31%
Profit Margin	-37.57%	-1.47%	-1.20%	6.31%	5.24%
Free Cash Flow Margin	-18.82%	16.70%	-7.37%	18.39%	-31.55%
EBITDA	-14.7	0.01	0.65	10.84	8.29
EBITDA Margin	-43.04%	0.01%	0.78%	9.46%	8.33%
D&A For EBITDA	0.01	0.01	0.03	0.02	0.02
EBIT	-14.7	-0	0.61	10.82	8.27
EBIT Margin	-43.05%	-0.00%	0.74%	9.44%	8.31%
Effective Tax Rate	-	-	2484.34%	24.92%	33.32%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.